KURARAY CO.,LTD. Q4 FY2025 earnings call

• Corporate Identity & Core Philosophy

  • Kuraray was founded in 1926, and will celebrate its 100th anniversary in June 2026. It operates as a global specialty chemical manufacturer with operations in 32 countries, an overseas sales ratio of 80%, and over 60% of total revenue coming from products with global No.1 market share.
  • The company's founding philosophy "Do what others cannot for the good of society and people" remains its core DNA, focused on developing unique, hard-to-replicate specialty chemical products.

• Core Business Strategy for Poval Resin

  • Kuraray has pivoted away from low-margin commodity Poval applications to focus exclusively on high-value-added uses (including PVC polymerization dispersants, specialty films, and modified PVB resin), which deliver higher profit margins and an expected 8% annual growth. This high-value focus has been a core strategic direction from the early days of the business, and the share of high-value products is expected to continue rising gradually going forward.
  • Poval resin operates a global production network of 6 facilities across Japan, the US, Germany, and Singapore, with a new technical center opened near the Singapore plant in September 2025 to strengthen regional technical support. The multi-location network also minimizes exposure to trade policy impacts such as US tariffs.

• Water-Soluble Poval Film Growth

  • Kuraray holds a near-monopoly market share in water-soluble Poval film for unit-dose laundry detergent pods, acquired via the 2012 purchase of MonoSol. The product benefits from Kuraray's integrated value chain, which allows for raw-to-finished product innovation.
  • Unit-dose laundry detergent penetration currently stands at 30% in Europe and the US, and is expected to rise to 50% over the next several years, with significant additional growth potential in penetration in underpenetrated markets like Japan and China. A new production facility in Poland opened in April 2025 to meet growing European demand.

• New Growth Initiatives

  • Kuraray launched the world's first PVA microcarrier for regenerative medicine (brand name Scapova) last year, based on its core Poval technology. The product delivers 2-3x higher cell proliferation rates than competing products, requires no pre-use processing, and has already achieved 100-liter bioreactor scaling. The company aims to build this into a tens of billions of yen level business by the 2030s-2040s.

• Business Portfolio Transformation

  • Kuraray evaluates all businesses across three metrics: social/environmental value, economic value, and market growth, classifying them into four categories: Growth/Expansion, Base, New Solutions, and Optimization/Restructuring. The company actively divests or withdraws from low-rated businesses that cannot be improved to allocate resources to higher potential areas.
  • The 2022-2026 mid-term management plan has accelerated portfolio rationalization, a shift driven by clearer visibility of business strengths and weaknesses after the COVID-19 pandemic. Optical Poval film, which holds an 80% global market share and delivers stable profits, is classified as a base business due to stagnant overall large TV market demand, and remains an important contributor to operating profit.

• Shareholder Return

  • Kuraray adopted a new shareholder return policy in February 2025, targeting a total payout ratio of 50% or higher of parent net income, with commitments to maintain/increase dividends per share and continue consistent share buybacks. For 2025, the company plans a full-year dividend of 54 yen per share and 30 billion yen in share buybacks, for a total projected payout ratio of 142%.

For the full year 2024, Kuraray reported consolidated net sales of 826.9 billion yen, consolidated operating profit of 85.1 billion yen, and an operating margin of 10.3%. The company organizes its business into four product segments, with the following revenue contribution breakdown: 1. Vinyl Acetate Segment: This is Kuraray's core business, accounting for approximately 50% of total company revenue, anchored by the company's world-first industrialization of Poval (polyvinyl alcohol) resin and downstream products including water-soluble Poval film, optical Poval film, and EVOH resin (brand name EVAL). 2. Functional Materials Segment: The second-largest segment, led by activated carbon (Kuraray is the world's largest activated carbon manufacturer following the 2018 acquisition of Calgon Carbon), with additional products including dental materials (zirconia-based materials for aesthetic dentistry) and optical-grade methacrylic resin/sheets. 3. Isoprene Segment: A smaller high-growth segment, anchored by the company's exclusive heat-resistant polyamide resin Genesta, which is seeing rapidly growing adoption in connectors for generative AI servers and EV battery components. 4. Fiber Segment: Kuraray's original foundational business, now accounting for approximately 7% of total revenue following decades of portfolio rebalancing.

• High-value-added Poval resin is expected to deliver 8% annual growth while maintaining high profit margins, with the share of high-value products in the overall Poval portfolio expected to rise gradually over time.
  • Penetration of unit-dose laundry detergent is projected to increase from 30% to 50% in Europe and North America over the next several years, bringing a 50% increase in market size for water-soluble Poval film. Kuraray expects to maintain its near-monopoly market share and capture this growth, which will have a material positive impact on group profits due to the product's high margins.
  • The Scapova PVA microcarrier for regenerative medicine is expected to see large market expansion in the 2030-2040 timeframe, and Kuraray targets reaching a tens of billions of yen annual revenue scale for this business in that period.
  • Kuraray is targeting early achievement of 10% ROE, after which it will aim for even higher ROE levels in line with global peer performance.
  • The company expects continued gradual growth in demand for water-soluble Poval film from new non-laundry applications as it expands use cases in personal care, cosmetics, and agricultural packaging, alongside sustainability improvements including increased use of bio-based raw materials and improved biodegradability.

• Geopolitical risk for the new Poland production facility is actively managed via Kuraray's enterprise risk management system, with business and corporate teams regularly assessing risks and implementing mitigating actions as needed.
  • The Poval resin plant in the US was temporarily shut down due to a utility failure at an external third-party supplier. While the incident did not meet the formal threshold for mandatory disclosure, Kuraray voluntarily disclosed it out of transparency as it is a major facility for a core business.
  • Rising raw material and energy costs are mitigated by Kuraray's strong market position in high-share specialty products, which allows for full or nearly full pass-through of cost increases to customers. The company's multi-location global production network also allows it to source raw materials from lowest-cost regions to balance overall input costs.
  • A future repeat of a large-scale pandemic disruption like COVID-19 is mitigated by Kuraray's highly diversified business exposure across multiple industries (packaging, consumer goods, automotive, electronics, construction, water treatment) with no single large concentration, which supports stable earnings even in systemic crises.

Q: How has Kuraray accelerated business portfolio rationalization and divestment in recent years? Is there a specific driver for this increased activity? / A: Kuraray has been optimizing its business portfolio for many years, not just recently. The COVID-19 pandemic created widespread market changes that made business strengths and weaknesses much clearer than before. Businesses that had previously generated modest profits but lacked long-term competitive advantages were able to be re-evaluated more clearly, leading to the recent increase in divestment and withdrawal activity. This aligns with the company's strategy of focusing resources on high-potential growth businesses. / Q: Will Kuraray's market share for water-soluble Poval film hold steady as the market grows from 30% to 50% penetration, or will new competitors erode share? / A: Kuraray holds a near-monopoly share in Poval film for unit-dose laundry detergent, and has collaborated with large global detergent makers on product development from the earliest stages of the category. The company expects to maintain its current market share while growing alongside the overall expanding market, capturing the full benefit of segment growth. / Q: What is Kuraray's plan for improving ROE and PBR, and is 10% ROE the final target? / A: The mid-term management plan targets 10% ROE by the 2026 final fiscal year, and current projections point to around 9% ROE, so the company is focused on hitting 10% as soon as possible. 10% ROE is not the final target: European and US specialty chemical firms typically achieve higher ROE levels, so Kuraray will work toward even higher ROE after hitting the 10% milestone. / Q: How does Kuraray approach capital allocation for capital expenditure amid portfolio restructuring? / A: Kuraray prioritizes and concentrates capital expenditure on its growth and expansion categorized businesses, and reduces spending in businesses targeted for restructuring or shrinkage. This focused allocation will create a more efficient capital structure once the current round of portfolio rationalization is complete. Going forward, the company plans to keep capital expenditure within the bounds of depreciation and operating cash flow.